dc.contributor.author | Karaburun, Ahmet Çağrı | |
dc.contributor.author | Gündoğdu-Karaburun, Nalan | |
dc.contributor.author | Yurttaş, Leyla | |
dc.contributor.author | Kayagil, İsmail | |
dc.contributor.author | Demirayak, Şeref | |
dc.date.accessioned | 2019-10-19T14:44:33Z | |
dc.date.available | 2019-10-19T14:44:33Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 1570-1808 | |
dc.identifier.issn | 1875-628X | |
dc.identifier.uri | https://dx.doi.org/10.2174/1570180815666180606081042 | |
dc.identifier.uri | https://hdl.handle.net/11421/13550 | |
dc.description | WOS: 000459738100002 | en_US |
dc.description.abstract | Background: The synthesis of 2-[3/4-((6-substituted-1-oxo-2,3-dihydro-1H-inden-2ylidene) methyl)phenoxy]-N-(heteroaryl)acetamide derivatives and the investigation of their anticancer activity were studied. Methods: 2-(3/4-Hydroxybenzylidene)-6-substituted-2,3-dihydro-1H-inden-1-ones were reacted with suitable 2-chloroacetamides to give 2-[3/4-((6-substituted-1-oxo-2,3-dihydro-1H-inden-2-ylidene)methyl) phenoxy]-N-(heteroaryl) acetamide derivatives. Results: The structure elucidation of the newly synthesised 16 compounds was performed by IR, 1H-NMR, mass spectroscopic data and elemental analyses. The anticancer screening was carried out in National Cancer Institute (NCI), USA. Conclusion: Compound 3e (2-(3-((6-chloro-1-oxo-2,3-dihydro-1H-inden-2-ylidene) methyl)phenoxy)N-(thiazol-2-yl)acetamide), exhibited highest growth inhibition against the leukaemia (61.47%), non-small cell lung cancer (79.31%) and breast cancer (62.82%) cell lines. | en_US |
dc.description.sponsorship | Anadolu University, Turkey (BAP) [050301] | en_US |
dc.description.sponsorship | This work was supported by Anadolu University, Turkey (BAP Project No: 050301). NCI, USA is gratefully acknowledged for investigating the anticancer activity. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Bentham Science Publ LTD | en_US |
dc.relation.isversionof | 10.2174/1570180815666180606081042 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Anticancer Activity | en_US |
dc.subject | Aurone Analogue | en_US |
dc.subject | Benzothiazoleacetamide | en_US |
dc.subject | 2,3-Dihydro-1H-Inden-1-One | en_US |
dc.subject | Thiazoleacetamide | en_US |
dc.subject | Leukaemia | en_US |
dc.title | Synthesis and Anticancer Activity of Some 1H-inden-1-one Substituted (Heteroaryl)Acetamide Derivatives | en_US |
dc.type | article | en_US |
dc.relation.journal | Letters in Drug Design & Discovery | en_US |
dc.contributor.department | Anadolu Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Anabilim Dalı | en_US |
dc.identifier.volume | 16 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 111 | en_US |
dc.identifier.endpage | 118 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.contributor.institutionauthor | Karaburun, Ahmet Çağrı | |
dc.contributor.institutionauthor | Gündoğdu-Karaburun, Nalan | |
dc.contributor.institutionauthor | Yurttaş, Leyla | |
dc.contributor.institutionauthor | Demirayak, Şeref | |